Raghav Sundar on New Ways to Potentially Reduce CIPN
Raghav Sundar, MBBS, MRCP, MMed, National University Health System, Singapore, discusses the development of a new device that may be able to reduce chemotherapy-induced peripheral neuropathy (CIPN).
Raghav Sundar, MBBS, MRCP, MMed, National University Health System, Singapore, discusses the development of a new device that may be able to reduce chemotherapy-induced peripheral neuropathy (CIPN).
The device that was developed covers and cools patients’ arms and legs during chemotherapy infusion. By decreasing the temperature and thereby the blood flow, a smaller amount of chemotherapy will end up in the extremities, preventing CIPN.
A clinical trial was conducted that involved patients with breast cancer who were receiving weekly placlitaxel (Abraxane) infusions. Patients were monitored with temperature sensors and nerve-conducting studies. The proof-of-concept study showed that this may be a promising method to reduce CIPN.
Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers
September 1st 2022In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.
Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors
July 16th 2024Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune checkpoint inhibitors to prevent permanent hearing loss and improve patients' quality of life.
